George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,000 shares at $955.00 ($950K) on 2024-02-09, disclosed to the SEC on 2024-02-12.
Open-market sale of $950k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $945.00 | 500 | $473K | 49.7% |
| 2 | $955.00 | 500 | $478K | 50.3% |
| Total | $950.00 avg | 1,000 | $950K | 100% |
| Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |
| REGN | SELL | 2021-11-18 | $7.0M | — | Filing → |